Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Sarcopenia is believed to be associated with disability and metabolic complications. The objective of this study was to examine the metabolic and quality-of-life profile of sarcopenic overweight and obese postmenopausal women. In this cross-sectional study of 136 healthy overweight and obese postmenopausal women, 9 class I sarcopenic women were identified. Class I sarcopenia was defined as an appendicular lean body mass index (ALBMI) ≤ 6.44 kg·m–2 (appendicular lean body mass/height). Outcome measures were body composition (dual energy X-ray absorptiometry and computed tomography), blood lipids, inflammation markers, blood pressure, insulin sensitivity (homeostasis model assessment and hyperinsulinemic-euglycemic clamp), cardiorespiratory fitness, and quality of life (Medical Outcomes Study General Health Survey questionnaire). By design, class I sarcopenic women (n = 9) had a significantly lower ALBMI and appendicular lean body mass than nonsarcopenic women (n = 127). In addition, class I sarcopenic women tended to have lower levels of insulin resistance (p = 0.070) and fasting glucose (p = 0.054). However, no difference between the groups was observed for quality of life. This study showed that, in our sample of class I sarcopenic overweight and obese postmenopausal women, subjects did not present an unfavourable metabolic or quality-of-life profile, compared with nonsarcopenic overweight and obese postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sarcopenic obesity (as defined by low appendicular lean mass normalized for height2 and increased BMI) was associated with unfavourable scores on the Medical Outcomes Survey234.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [234]
In the citing paper
“Moreover, several cross-sectional studies have reported that older adults with sarcopenic obesity [based on DXA-measured ALM/weight (%) and % body fat or BMI] did not have a significantly higher prevalence of CVD than adults without sarcopenia or obesity (34, 95–97).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [96]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Moreover, homeostasis model assessment was calculated, as proposed by Matthews et al. (1985), using 3 basal values of fasting serum glucose and insulin (ðfasting insulin fasting glucoseÞ=22:5), where fasting insulin is measured as mU mL–1, and fasting glucose is measured as mmol L–1).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Measuring Health: A Guide to Rating Scales and Questionnaires
McDowell, I., & Newell, C. (1987) · Cited by 4,207
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 7×
“Moreover, sarcopenia may affect quality of life and lead to functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002).”
BackgroundMethodInfluentialJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 5×
“Moreover, sarcopenia may affect quality of life and lead to functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002).”
BackgroundInfluentialStewart, A. L. (1989) · JAMA · doi:10.1001/jama.262.7.907 · Cited by 2,085
Stewart, A. L. (1989) · JAMA · doi:10.1001/jama.1989.03430070055030 · Cited by 1,735 · cited 2×
“…using a validated selfadministered questionnaire (Medical Outcomes Study General Health Survey), which evaluated quality-of-life subscales for physical functioning, pain, social functioning, role functioning, mental health, and health perceptions (Stewart et al. 1989; McDowell and Newell 1996).”
MethodLau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154 · cited 2×
“However, our results indicate that class I sarcopenic women did not display an unfavourable metabolic profile; it was comparable to that of nonsarcopenic women in most of the measured parameters, despite a higher percentage of fat mass, a well known correlate of adverse metabolic outcomes (Lau et al. 2007).”
ResultGoodpaster, B. H., Leland Thaete, F., Simoneau, J.-A., & Kelley, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1579 · Cited by 1,012 · cited 1×
“Second, it could be related to reduced muscle lipid infiltration, which has been associated with higher insulin sensitivity (Goodpaster et al. 1997).”
BackgroundMorley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., & Nair, K. S. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.113504 · Cited by 936 · cited 2×
“…that the loss of skeletal muscle mass observed with advancing age is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker for disability (Visser…”
Background
Research works printed but not linked: 5
- Bastard, J.P., and Rabasa-Lhoret, R. 2005. Mesurer l’insulino-résistance. In Traité de diabétologie. Edited by A. Grimaldi. Médecine-Sciences Flammarion, Paris, France. pp. 90–96.
- DeFronzo R.A., 1979, Am. J. Physiol., 237, E214
- 10.2337/diabetes.46.10.1579 · DOI · Paper page
- Henriksen E.J., 1990, Am. J. Physiol., 259, E593
- James D.E., 1985, Am. J. Physiol., 248, E567
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
Weight gain in breast cancer survivors: prevalence, pattern and health consequences
Vance, V., Mourtzakis, M., McCargar, L., & Hanning, R. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00805.x · Cited by 409
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Menopause and sarcopenia: A potential role for sex hormones
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.01.014 · Cited by 397
“[13] observed that insulin resistance and fasting glucose tended to be lower in obese sarcopenic women compared to obese nonsarcopenicwomen.”
BackgroundResultSelf-citationSarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344
“Several cross-sectional studies have reported that obese individuals have more cardiovascular risk factors than those with sarcopenic obesity [59,60].”
BackgroundHealth Consequences of Sarcopenic Obesity: A Narrative Review
Roh, E., & Choi, K. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00332 · Cited by 304
Kim, T. N., Park, M. S., Lim, K. I., Choi, H. Y., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Choi, H., Baik, S. H., et al. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04433.x · Cited by 208
Polyzos, S. A., & Margioris, A. N. (2018) · Hormones · doi:10.1007/s42000-018-0049-x · Cited by 212
“In the KNHNES, sarcopenic obesity was inversely associated with QoL [5], an association that was more robust in participants under the age of 60.”
BackgroundInfluentialSarcopenic obesity in ageing: cardiovascular outcomes and mortality
Atkins, J. L., & Wannamathee, S. G. (2020) · British Journal of Nutrition · doi:10.1017/s0007114520002172 · Cited by 187
“Similar associations found in men although not significant Messier et al.(70) 2009 Cross-sectional n 136 Healthy overweight or obese postmenopausal women Aged 46–70 years DXA (ASM); CT Sarcopenic overweight/obese women did not show a higher risk metabolic profile compared with non-sarcopenic overweight/obese women”
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176
Sarcopenic obesity in aging population: current status and future directions for research
Kohara, K. (2014) · Endocrine · doi:10.1007/s12020-013-9992-0 · Cited by 171
Khadra, D., Itani, L., Tannir, H., Kreidieh, D., Masri, D. E., & Ghoch, M. E. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.311 · Cited by 130
Metabolically healthy but obese individuals: relationship with hepatic enzymes
Messier, V., Karelis, A. D., Robillard, M.-È., Bellefeuille, P., Brochu, M., Lavoie, J.-M., & RABASA-LHORET, R. P. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.020 · Cited by 138
“Methods for body composition, body fat distribution, blood samples, and oral glucose tolerance tests (OGTTs) were determined as previously described [19-21].”
MethodSelf-citationMarriott, C., Beaumont, L. F., Farncombe, T. H., Cranston, A., Athale, U. H., Yakemchuk, V. N., Webber, C. E., & Barr, R. D. (2017) · Cancer · doi:10.1002/cncr.31191 · Cited by 84
Pedrero-Chamizo, R., Gómez-Cabello, A., Mélendez, A., Vila-Maldonado, S., Espino, L., Gusi, N., Villa, G., Casajús, J. A., González-Gross, M., & Ara, I. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0530-4 · Cited by 76
“On the other hand, several studies have not found functional differences between normal and SO groups or have reported that BF is the most important risk marker for disability (7, 9, 30).”
The effects of lifestyle interventions in dynapenic-obese postmenopausal women
Sénéchal, M., Bouchard, D. R., Dionne, I. J., & Brochu, M. (2012) · Menopause · doi:10.1097/gme.0b013e318248f50f · Cited by 48
Self-citationCurrent review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia
Beaudart, C., Reginster, J., Geerinck, A., Locquet, M., & Bruyère, O. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1360768 · Cited by 56
“Reference Sarcopenia diagnostic criteria QoL tool(s) used Results Beaudart [27] EWGSOP [3] SF-36 EQ-5D EQ-VAS Poorer QoL of sarcopenic patients only for physical functioning No difference in QoL between groups No difference in QoL between groups Go [28] ALM/ht2 <2SD of the sex-specific means of young adults EQ-5D Lowe…”
BackgroundInfluentialAlalwan, T. A. (2020) · Geriatrics · doi:10.3390/geriatrics5010008 · Cited by 46
“[40], sarcopenic obese postmenopausal women did not present an unfavorable metabolic profile compared with those who were not sarcopenic obese.”
BackgroundUnderstanding Sarcopenic Obesity in Terms of Definition and Health Consequences: A Clinical Review
Nezameddin, R., Itani, L., Kreidieh, D., El Masri, D., Tannir, H., & El Ghoch, M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200109091449 · Cited by 38
Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study
Aubertin‐Leheudre, M., Anton, S. D., Beavers, D. P., Manini, T. M., Fielding, R. A., Newman, A. B., Church, T., Kritchevsky, S. B., Conroy, D. E., McDermott, M. M., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.10.001 · Cited by 41
Barbat-Artigas, S., Filion, M.-E., Plouffe, S., & Aubertin-Leheudre, M. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0092 · Cited by 35
“Muscle fiber type has been suggested to be involved in the sarcopenic and metabolically healthy but obese paradoxes.(2,4) Our results do not support this statement.”
Influence of Severe Sarcopenia on Cardiovascular Risk Factors in Nonobese Men
Abe, T., Thiebaud, R. S., Loenneke, J. P., Bemben, M. G., Loftin, M., & Fukunaga, T. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0057 · Cited by 36
Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification
Jun, J. E., Kang, M., Jin, S.-M., Kim, K., Hwang, Y.-C., Jeong, I.-K., & Kim, J. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0885 · Cited by 27
Mankowski, R. T., Anton, S. D., & Aubertin‐Leheudre, M. (2015) · Current Geriatrics Reports · doi:10.1007/s13670-015-0132-y · Cited by 34
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk
Singh, P., Covassin, N., Marlatt, K. L., Gadde, K. M., & Heymsfield, S. B. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210014 · Cited by 56
Khadra, D., Itani, L., Chebaro, Y., Obeid, M., Jaber, M., Ghanem, R., Ayton, A. K., Kreidieh, D., Masri, D. E., Kimura, A., et al. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16666200214104122 · Cited by 24
“metabolic and cardiovascular diseases) [5, 6, 8-15], with the speculation that the two components of SO, namely the increase of fat deposition and the reduction in muscle mass and strength, seem to act synergistically to increase the adverse consequences on health, but this hypothesis has not been confirmed [16-18].”
BackgroundSarcopenic obesity: patterns and paradoxes
Drapkina, O. M., Budnevsky, A. V., Ovsyannikov, Е. S., Васильевна, К. А., & Дробышева, Е. С. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20212401173 · Cited by 21
van den Berg, M. M. G. A., Kok, D. E. G., Visser, M., de Vries, J. H. M., de Kruif, A. J. T. C. M., de Vries, Y., Posthuma, L., Sommeijer, D. W., Timmer-Bonte, A. N., Los, M., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04951-6 · Cited by 27
Ji, W., Liu, X., Zheng, K., Liu, P., Zhao, Y., Lü, J., Zhao, L., Liang, T., Cui, J., & Li, W. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.033 · Cited by 21
Understanding the development of sarcopenic obesity
Gross, D. C., Cheever, C. R., & Batsis, J. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267672 · Cited by 21
“A cross-sectional study comparing a limited number ( n = 9) postmenopausal women with SarcO to a larger number ( n = 127) of postmenopausal women with persons without SarcO did not find any differences in outcomes [30].”
Akwa, L. G., Moses, M. O., Emikpe, A. O., Baffour-Awuah, B., Asamoah, B., Addai‐Mensah, O., Annani-Akollor, M. E., Osei, F., & Appiah, E. J. (2017) · Journal of Human Sport and Exercise · doi:10.14198/jhse.2017.123.14 · Cited by 22
“A study concluded after sensitivity analyses that, aerobic exercise only increases HDL-C while decreasing the cardiovascular risk ratio in older adults (Millan et al., 2009).”
BackgroundThe effect of sarcopenic obesity on cardiovascular disease and all-cause mortality in older people
Atkins, J. L., & Wannamethee, S. G. (2015) · Reviews in Clinical Gerontology · doi:10.1017/s0959259815000076 · Cited by 18
Kuczmarski, M. F., Weddle, D. O., & Jones, E. M. (2010) · Journal of Nutrition for the Elderly · doi:10.1080/01639366.2010.499093 · Cited by 24
“The loss of skeletal muscle mass with aging, known as sarcopenia, can have a negative impact on physical activity, possibly affecting QOL (2, 5, 7, 8).”
BackgroundInfluentialWigodski, S., Carrasco, F., Bunout, D. C., Barrera, G., Hirsch, S., & de la Maza, M. P. (2018) · Nutrition · doi:10.1016/j.nut.2018.05.031 · Cited by 19
Matta, J., Mayo, N. E., Dionne, I. J., Gaudreau, P., Fülöp, T., Tessier, D., Gray‐Donald, K., Shatenstein, B., & Morais, J. A. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0554-4 · Cited by 17
“Our results are consistent with those showing that sarcopenic women had lower levels of insulin resistance than non sarcopenic ones (42).”
Body composition in sarcopenic obesity: systematic review of the literature
Donini, L. M., Poggiogalle, E., Migliaccio, S., Aversa, A., & Pinto, A. (2013) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-013-0135-1 · Cited by 31
Huang, S., Lee, Y.-H., Liao, C., Escorpizo, R. S., Liou, T., & Lin, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-54102-z · Cited by 17
“A study reported a link between SO and unfavorable results on the Medical Outcomes Survey 29 .”
BackgroundItani, L., Kreidieh, D., Masri, D. E., Tannir, H., & Ghoch, M. E. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200211102057 · Cited by 14
Effects of Sarcopenic Obesity on Cardiovascular Disease and All-Cause Mortality
Atkins, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00007-5 · Cited by 11
dos Santos, V. R., Christófaro, D. G. D., Gomes, I. C., Viezel, J., Júnior, I. F. F., & Gobbo, L. A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.019 · Cited by 10
Paolillo, F. R., Milan, J. C., Paolillo, A. R., Lopes, S. L. B., Kurachi, C., Bagnato, V. S., & Borghi‐Silva, A. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0132-4 · Cited by 7
“Changes in body composition have been observed in postmenopausal women, due to hormonal changes [1].”
BackgroundBarbat‐Artigas, S., Filion, M., Ringuet, M.-È., Aubertin‐Leheudre, M., & Karelis, A. D. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.08.001 · Cited by 7
Self-citationQuality of Life and Sarcopenia
Beaudart, C., Reginster, J., Bruyère, O., & Geerinck, A. (2021) · Wiley eBooks · doi:10.1002/9781119597896.ch21 · Cited by 7
González-Gutiérrez, J., Gómez, J. J. L., Primo, D., Izaola-Jáuregui, O., Ramos-Bachiller, B., Jiménez-Sahagún, R., & de Luis, D. A. (2025) · Nutrition · doi:10.1016/j.nut.2025.112765 · Cited by 3
How to evaluate quality of life in overweight and obese women during climacterium?
Munhoz, L. O., Sorpreso, I. C. E., Nogueira, M. C. C., Simões, R. S., Soares, J. M., & Baracat, E. C. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.05.018 · Cited by 2
Management of Sarcopenia to Improve Quality of Life in Geriatric Populations
Yu (2016) · Clinical Medicine Insights Geriatrics · doi:10.4137/cmger.s12302 · Cited by 4
Han, L., Su, W., Zheng, Z., Li, J., Wang, S., Chen, Z., Zhang, Y., Huang, B., Lyu, F., Yan, F., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15978 · Cited by 2
“3,4 A key factor contributing to these inconsistent findings lies in the absence of a standardized definition of sarcopenic obesity, leading to variations across diverse studies.”
Clinical aspect of sarcopenic obesity
Kohara, K. (2013) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.50.773 · Cited by 1
Loss of Muscle Mass and Muscle Strength in Obese and Nonobese Older Adults
B̀ouchard, D. R., & Janssen, I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_6 · Cited by 2
Jakubiec, D., Jarnut, W., Jonak, W., Chromik, K., & Sobiech, K. A. (2012) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2012.32541
Bilginer, M. C., & Kavgacı, H. (2021) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.880502 · Cited by 1
Waist circumference as a mediator in the association between sarcopenia and cognitive function
Xu, C., Fu, J., Zhang, K., Wang, Y., Liu, X., Mubarik, S., Shi, W., Zhang, S., & Wang, F. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427037
“45,46 Meanwhile, cardiovascular diseases such as stroke are also signi fi cant risk factors for cognitive impairment.”
Metadata
- Authors
- Messier, V., Karelis, A. D., Lavoie, M.-E., Brochu, M., Faraj, M., Strychar, I., & Rabasa-Lhoret, R.
- Affiliations
- Université de Sherbrooke (CA)
- Département de Nutrition, Université de Montréal, 2405, chemin Cote Ste-Catherine, Montreal, QC H3T 1A8, Canada.
- Venue
- Applied Physiology, Nutrition, and Metabolism
- Publisher
- Canadian Science Publishing
- Published
- 2009-02
- Volume
- 34
- Issue
- 1
- Pages
- 18-24
- ISSN
- 1715-5312 (ISSN-L)
- 1715-5320
- OpenAlex
- W2046236289
- Cited by
- 54
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Applied Physiology Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Ottawa
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenia, postmenopausal women, obesity, overweight, metabolic profile, quality of life, insulin resistance, body composition, cardiorespiratory fitness, serum lipids, inflammatory markers, fasting blood glucose
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Cross-Sectional Studies, Female, Humans, Insulin, Insulin Resistance, Lipids, Middle Aged, Muscular Atrophy, Obesity, Physical Fitness, Quality of Life, Surveys and Questionnaires, Body Mass Index, Postmenopause, Inflammation Mediators, Overweight, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.